XyloCor Therapeutics Company
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.
Industry:
Gene Therapy
Technology:
Cardiovascular Disorders
Headquarters:
Malvern, Pennsylvania, United States
Founded Date:
2013
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M